Analogic Plans to Accelerate Expansion Into Point-of-Care Market Upon
Completion of Ultrasonix Acquisition
Combination of BK Medical and Ultrasonix Builds Strong Ultrasound Product
PEABODY, Mass., Jan. 29, 2013 (GLOBE NEWSWIRE) -- Analogic Corporation
(Nasdaq:ALOG), enabling the world's medical imaging and aviation security
technology, confirmed its support for the Ultrasonix product line upon
completion of the acquisition of Ultrasonix Medical Corporation, a supplier of
advanced ultrasound systems for point-of-care and general imaging
applications. Ultrasonix has over 5,000 systems installed worldwide, and would
bring key ultrasound products, technology, and sales channels that are
complementary to Analogic's ultrasound business.
"Once the acquisition is complete, Ultrasonix will be a significant
contributor to Analogic's Ultrasound Group," said Farley Peechatka, senior
vice president and general manager, Global Ultrasound Business, Analogic.
"With a solid installed base, superb portfolio of ultrasound products, unique
GPS technology for needle guidance, and intuitive graphical user interface,
Ultrasonix will help accelerate our presence and growth in point-of-care
applications in developed countries, and general imaging in emerging markets.
We will continue to improve and advance both the Ultrasonix and BK Medical
product lines to ensure that existing and new customers get the best products,
support, and service that we can offer."
Analogic and Ultrasonix are recognized as two of the world's leading producers
of portable, procedure-driven, guided ultrasound technology. Founded in 2000,
Ultrasonix has a broad portfolio of both portable and cart-based ultrasound
systems with a recognized brand used primarily for point-of-care applications
such as emergency medicine, anesthesia, and reproductive medicine, as well as
general imaging in emerging markets. Analogic's BK Medical ultrasound
solutions are used to improve the practice of medicine in procedure-driven
markets—urology, surgery, and anesthesia. BK Medical's products, including its
award-winning Flex Focus™ family of systems and unique transducer designs,
offer advanced imaging capabilities that enable real-time image guidance in an
easy-to-use, portable platform.
"We are eager to bring these comprehensive and complementary product
portfolios together for an even stronger suite of advanced ultrasound systems
for customers of both companies," said Lars Shaw, vice president of global
marketing at Analogic. "In the point-of-care market, we believe our combined
Anesthesia product portfolio will be much stronger. We anticipate that
Ultrasonix will also complement our existing BK Medical urology and surgery
product portfolio for both the hospital and office-based practice. We will
continue to support Ultrasonix reproductive medicine customers with innovative
technologies. Ultrasonix general imaging products are targeted for fast
growing, emerging markets, which should allow us to better address emerging
markets with a strong product portfolio."
The acquisition transaction is expected to close in late February 2013.
Any statements about future expectations, plans, and prospects for the
Company, including statements containing the words " believes," "
anticipates," " plans," " expects," and similar expressions, constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Actual results may differ materially from those
indicated by such forward-looking statements as a result of various important
factors, including risks relating to product development and
commercialization, limited demand for the Company's products, risks associated
with competition, uncertainties associated with regulatory agency approvals,
competitive pricing pressures, downturns in the economy, the risk of potential
intellectual property litigation, and other factors discussed in our most
recent quarterly report filed with the Securities and Exchange Commission. In
addition, the forward-looking statements included in this presentation
represent the Company's views as of the date of this document. While the
Company anticipates that subsequent events and developments will cause the
Company's views to change, the Company specifically disclaims any obligation
to update these forward-looking statements. These forward-looking statements
should not be relied upon as representing the Company's views as of any later
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security
technology solutions to advance the practice of medicine and save lives. We
are recognized around the world for advanced imaging systems and technology
that enable computed tomography, ultrasound, digital mammography, and magnetic
resonance imaging (MRI), as well as automated threat detection for aviation
security. Our CT, MRI, digital mammography, and ultrasound transducer products
are sold to original equipment manufacturers (OEMs), providing
state-of-the-art capability and enabling them to enter new markets and expand
their existing market presence. Our market-leading BK Medical branded
ultrasound systems are sold to clinical end users through our direct sales
force. For over 40 years we've enabled customers to thrive, improving the
health and enhancing the safety of people around the world. Analogic is
headquartered just north of Boston, Massachusetts. For more information, visit
Ultrasonix develops and manufactures diagnostic ultrasound imaging systems
designed to make ultrasound easy to use in more areas of patient care. The
company's customizable systems are built on an open software platform that
enables remote service and easy updates to keep current with advancements in
imaging technology. Founded in 2000, Ultrasonix is headquartered in Richmond,
British Columbia, Canada.
Analogic is a registered trademark of Analogic Corporation.
The globe logo is a trademark of Analogic Corporation.
CONTACT: Investor Contact:
Director of Investor Relations
Press spacebar to pause and continue. Press esc to stop.